{"DataElement":{"publicId":"6514357","version":"1","preferredName":"Pathologic Details Identifiation","preferredDefinition":"The text term used to describe details about the patient's disease or medical condition found during a pathologic review.","longName":"pathology_details","context":"GDC","contextVersion":"1","DataElementConcept":{"publicId":"6514331","version":"1","preferredName":"Pathologic Finding Identification","preferredDefinition":"Caused by or altered by or manifesting disease or pathology._Clinical, laboratory or molecular evidence, or absence of evidence of disease._The procedure of having an identity established.","longName":"6514329v1.0:2322316v1.0","context":"GDC","contextVersion":"1","ObjectClass":{"publicId":"6514329","version":"1","preferredName":"Pathologic Finding","preferredDefinition":"Caused by or altered by or manifesting disease or pathology.:Clinical, laboratory or molecular evidence, or absence of evidence of disease.","longName":"C25610:C3367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7884A5FC-FBC4-7ADF-E053-F662850A9A90","latestVersionIndicator":"Yes","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"ONEDATA","dateModified":"2018-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2322316","version":"1","preferredName":"Identified","preferredDefinition":"Identified; having the identity known or established.","longName":"C25737","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Identification","conceptCode":"C25737","definition":"The procedure of having an identity established.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD0F852B-0624-7140-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-03","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-08-03","modifiedBy":"ONEDATA","dateModified":"2005-08-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"GDC:NCI Genomic Data Commons","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7884A5FC-FBD2-7ADF-E053-F662850A9A90","latestVersionIndicator":"Yes","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"COOPERM","dateModified":"2018-10-19","changeDescription":"Created for CDE Request for the GDC 10.17.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6514322","version":"1","preferredName":"Pathologic Finding Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"6514322v1.0","context":"GDC","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not Reported","valueDescription":"Not Reported","ValueMeaning":{"publicId":"2572578","version":"1","preferredName":"Not Reported","longName":"2572578","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E88F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-12-30","modifiedBy":"DWARZEL","dateModified":"2018-03-26","changeDescription":"03/09/2011 - tc - Updated with concept code.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7884A5FC-FA97-7ADF-E053-F662850A9A90","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"ONEDATA","dateModified":"2018-10-18","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"3104212","version":"1","preferredName":"Unknown","longName":"3104212v1.00","preferredDefinition":"Not known, observed, recorded; or reported as unknown by the data contributor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87F3C580-06F4-1DC3-E040-BB89AD434E7E","latestVersionIndicator":"Yes","beginDate":"2010-06-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-01","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":"Concept annotated for UPitt/TCGA.  Ylu, 01/30/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7884A5FC-FAA2-7ADF-E053-F662850A9A90","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"ONEDATA","dateModified":"2018-10-18","deletedIndicator":"No"},{"value":"Gastric Polyp(s)","valueDescription":"Gastric Polyp","ValueMeaning":{"publicId":"6514324","version":"1","preferredName":"Gastric Polyp","longName":"6514324","preferredDefinition":"A polyp that arises from the stomach.  This category includes neoplastic polyps (intestinal-type adenomatous polyps, gastric-type adenomas, and fundic gland polyps), and non-neoplastic polyps (hyperplastic polyps and hamartomatous polyps).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Polyp","conceptCode":"C3954","definition":"A polyp that arises from the stomach.  This category includes neoplastic polyps (intestinal-type adenomatous polyps, gastric-type adenomas, and fundic gland polyps), and non-neoplastic polyps (hyperplastic polyps and hamartomatous polyps).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7884A5FC-FAAF-7ADF-E053-F662850A9A90","latestVersionIndicator":"Yes","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"ONEDATA","dateModified":"2018-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7884A5FC-FAC8-7ADF-E053-F662850A9A90","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"ONEDATA","dateModified":"2018-10-18","deletedIndicator":"No"},{"value":"Autoimmune Atrophic Chronic Gastritis","valueDescription":"Autoimmune Atrophic Chronic Gastritis","ValueMeaning":{"publicId":"6514325","version":"1","preferredName":"Autoimmune Atrophic Chronic Gastritis","longName":"6514325","preferredDefinition":"Chronic atrophic gastritis that is caused by autoimmune destruction of parietal cells in the stomach resulting in hypochlorhydria and decreased production of intrinsic factor. It is characterized by atrophy of the oxyntic mucosa and enterochromaffin-like (ECL) cell hyperplasia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Autoimmune Atrophic Chronic Gastritis","conceptCode":"C156076","definition":"Chronic atrophic gastritis that is caused by autoimmune destruction of parietal cells in the stomach resulting in hypochlorhydria and decreased production of intrinsic factor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7884A5FC-FAD2-7ADF-E053-F662850A9A90","latestVersionIndicator":"Yes","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"COOPERM","dateModified":"2018-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7884A5FC-FAEB-7ADF-E053-F662850A9A90","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"ONEDATA","dateModified":"2018-10-18","deletedIndicator":"No"},{"value":"Helicobacter Pylori-Associated Gastritis","valueDescription":"Helicobacter Pylori-Associated Gastritis","ValueMeaning":{"publicId":"6270556","version":"1","preferredName":"Helicobacter Pylori-Associated Gastritis","longName":"6270556","preferredDefinition":"Inflammation of the stomach that is associated with Helicobacter Pylori.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Helicobacter Pylori-Associated Gastritis","conceptCode":"C27121","definition":"Inflammation of the stomach that is associated with Helicobacter Pylori.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA5693B-FA62-4FB6-E053-F662850A1EAE","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"ONEDATA","dateModified":"2018-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7884A5FC-FAFF-7ADF-E053-F662850A9A90","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"ONEDATA","dateModified":"2018-10-18","deletedIndicator":"No"},{"value":"Intestinal Metaplasia","valueDescription":"Intestinal Metaplasia","ValueMeaning":{"publicId":"3250504","version":"1","preferredName":"Intestinal Metaplasia","longName":"3250504","preferredDefinition":"A morphologic finding indicating the replacement of epithelial tissue outside the intestines by intestinal-type epithelium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intestinal Metaplasia","conceptCode":"C8360","definition":"A morphologic finding indicating the replacement of epithelial tissue outside the intestines by intestinal-type epithelium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6F215E6-C73C-B293-E040-BB89AD432EF3","latestVersionIndicator":"Yes","beginDate":"2011-06-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-30","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7884A5FC-FB09-7ADF-E053-F662850A9A90","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"ONEDATA","dateModified":"2018-10-18","deletedIndicator":"No"},{"value":"Cholelithiasis","valueDescription":"Cholelithiasis","ValueMeaning":{"publicId":"6514326","version":"1","preferredName":"Cholelithiasis","longName":"6514326","preferredDefinition":"The presence of calculi in the gallbladder.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cholelithiasis","conceptCode":"C122822","definition":"The presence of calculi in the gallbladder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7884A5FC-FB15-7ADF-E053-F662850A9A90","latestVersionIndicator":"Yes","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"ONEDATA","dateModified":"2018-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7884A5FC-FB2E-7ADF-E053-F662850A9A90","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"ONEDATA","dateModified":"2018-10-18","deletedIndicator":"No"},{"value":"High Grade Dysplasia","valueDescription":"High Grade Dysplasia","ValueMeaning":{"publicId":"6514327","version":"1","preferredName":"High Grade Dysplasia","longName":"6514327","preferredDefinition":"A subjective characterization of the phenomenon of dysplasia, based on microscopic examination of the architectural and/or cytological changes in a tissue sample, that is determined to be high.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Grade Dysplasia","conceptCode":"C156083","definition":"A subjective characterization of the phenomenon of dysplasia, based on microscopic examination of the architectural and/or cytological changes in a tissue sample, that is determined to be high.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7884A5FC-FB38-7ADF-E053-F662850A9A90","latestVersionIndicator":"Yes","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"COOPERM","dateModified":"2018-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7884A5FC-FB50-7ADF-E053-F662850A9A90","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"ONEDATA","dateModified":"2018-10-18","deletedIndicator":"No"},{"value":"Low Grade Dysplasia","valueDescription":"Low Grade Dysplasia","ValueMeaning":{"publicId":"6514328","version":"1","preferredName":"Low Grade Dysplasia","longName":"6514328","preferredDefinition":"A subjective characterization of the phenomenon of dysplasia, based on microscopic examination of the architectural and/or cytological changes in a tissue sample, that is determined to be low.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Grade Dysplasia","conceptCode":"C156084","definition":"A subjective characterization of the phenomenon of dysplasia, based on microscopic examination of the architectural and/or cytological changes in a tissue sample, that is determined to be low.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7884A5FC-FB5B-7ADF-E053-F662850A9A90","latestVersionIndicator":"Yes","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"COOPERM","dateModified":"2018-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7884A5FC-FB73-7ADF-E053-F662850A9A90","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"ONEDATA","dateModified":"2018-10-18","deletedIndicator":"No"},{"value":"Chronic hepatitis","valueDescription":"Chronic Hepatitis","ValueMeaning":{"publicId":"6423725","version":"1","preferredName":"Chronic Hepatitis","longName":"6423725","preferredDefinition":"An active inflammatory process affecting the liver for more than six months. Causes include viral infections, autoimmune disorders, drugs, and metabolic disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Hepatitis","conceptCode":"C82978","definition":"An active inflammatory process affecting the liver for more than six months. Causes include viral infections, autoimmune disorders, drugs, and metabolic disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7520DCD0-87E0-03F6-E053-F662850A2332","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7884A5FC-FB7E-7ADF-E053-F662850A9A90","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"ONEDATA","dateModified":"2018-10-18","deletedIndicator":"No"},{"value":"Cirrhosis","valueDescription":"Cirrhosis","ValueMeaning":{"publicId":"4618018","version":"1","preferredName":"Cirrhosis","longName":"4618018","preferredDefinition":"A chronic degenerative disease of the liver characterized by parenchymal nodularity and fibrosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cirrhosis","conceptCode":"C2951","definition":"A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09518164-CFAC-8FD3-E050-BB89AD433831","latestVersionIndicator":"Yes","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7884A5FC-FB88-7ADF-E053-F662850A9A90","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"ONEDATA","dateModified":"2018-10-18","deletedIndicator":"No"},{"value":"Fibrosis","valueDescription":"Fibrosis","ValueMeaning":{"publicId":"4264818","version":"1","preferredName":"Fibrosis","longName":"4264818","preferredDefinition":"The formation of fibrous tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibrosis","conceptCode":"C3044","definition":"The formation of fibrous tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F67A42EF-FCDE-5F77-E040-BB89AD433177","latestVersionIndicator":"Yes","beginDate":"2014-04-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-07","modifiedBy":"COOPERM","dateModified":"2020-10-16","changeDescription":"10.16.2020 Updated definition to match current NCIt. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7884A5FC-FB92-7ADF-E053-F662850A9A90","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"ONEDATA","dateModified":"2018-10-18","deletedIndicator":"No"},{"value":"Iron overload","valueDescription":"Iron Overload","ValueMeaning":{"publicId":"2945194","version":"1","preferredName":"Iron Overload","longName":"2945194","preferredDefinition":"Accumulation of iron in the tissues. It may be a manifestation of an inherited disorder (e.g., hemochromatosis) or acquired (in patients with repeated blood transfusions). Symptoms include hepatomegaly, arthritis, diabetes mellitus, and bronzed skin. If untreated it has a progressive course and may lead to death.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Iron Overload","conceptCode":"C78393","definition":"Accumulation of iron in the tissues. It may be a manifestation of an inherited disorder (e.g., hemochromatosis) or acquired (in patients with repeated blood transfusions). Symptoms include hepatomegaly, arthritis, diabetes mellitus, and bronzed skin. If untreated it has a progressive course and may lead to death.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"745580E8-4272-8FA9-E040-BB89AD433702","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7884A5FC-FB9C-7ADF-E053-F662850A9A90","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"ONEDATA","dateModified":"2018-10-18","deletedIndicator":"No"},{"value":"Primary sclerosing cholangitis","valueDescription":"Primary Sclerosing Cholangitis","ValueMeaning":{"publicId":"3210800","version":"1","preferredName":"Primary Sclerosing Cholangitis","longName":"3210800","preferredDefinition":"A chronic, autoimmune inflammatory liver disorder characterized by narrowing and scarring of the lumen of the bile ducts. It is often seen in patients with ulcerative colitis. Signs and symptoms include jaundice, fatigue, and malabsorption. It may lead to cirrhosis and liver failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Sclerosing Cholangitis","conceptCode":"C4828","definition":"A chronic, autoimmune inflammatory liver disorder characterized by narrowing and scarring of the lumen of the bile ducts. It is often seen in patients with ulcerative colitis. Signs and symptoms include jaundice, fatigue, and malabsorption. It may lead to cirrhosis and liver failure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-A1CC-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7884A5FC-FBA6-7ADF-E053-F662850A9A90","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"ONEDATA","dateModified":"2018-10-18","deletedIndicator":"No"},{"value":"Steatosis","valueDescription":"Steatosis","ValueMeaning":{"publicId":"3249618","version":"1","preferredName":"Steatosis","longName":"3249618","preferredDefinition":"A morphologic finding indicating intracytoplasmic fat accumulation in the liver parenchyma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Steatosis","conceptCode":"C36185","definition":"Acumulation of adipose tissue in intracytoplasmic or extracellular spaces.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6D9FB96-3598-EB3C-E040-BB89AD435DB4","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7884A5FC-FBBA-7ADF-E053-F662850A9A90","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"ONEDATA","dateModified":"2018-10-18","deletedIndicator":"No"},{"value":"Nonalcoholic Steatohepatitis","valueDescription":"Nonalcoholic Steatohepatitis","ValueMeaning":{"publicId":"3210796","version":"1","preferredName":"Nonalcoholic Steatohepatitis","longName":"3210796","preferredDefinition":"Fatty replacement and damage to the hepatocytes not related to alcohol use. It may lead to cirrhosis and liver failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nonalcoholic Steatohepatitis","conceptCode":"C84445","definition":"Fatty replacement and damage to the hepatocytes not related to alcohol use. It may lead to cirrhosis and liver failure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-A132-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7895D879-B9E0-2C36-E053-F662850A1967","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-19","modifiedBy":"ONEDATA","dateModified":"2018-10-19","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"GDC:NCI Genomic Data Commons","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7884A5FC-FA7F-7ADF-E053-F662850A9A90","latestVersionIndicator":"Yes","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"COOPERM","dateModified":"2018-10-19","changeDescription":"Created for CDE Request for the GDC 10.17.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5428034","version":"1","longName":"Clinical","context":"GDC","ClassificationSchemeItems":[{"publicId":"10000695","version":"1","longName":"Diagnosis","context":"GDC"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Pathology Details","type":"Preferred Question Text","description":"Pathology Details","url":null,"context":"GDC"}],"origin":"GDC:NCI Genomic Data Commons","workflowStatus":"RELEASED","registrationStatus":"Application","id":"78863E94-F21A-4C81-E053-F662850AD839","latestVersionIndicator":"Yes","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"COOPERM","dateModified":"2018-10-19","changeDescription":"Created for CDE Request for the GDC 10.17.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}